Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

BACKGROUND: Pathogenesis in non-alcoholic steatohepatitis (NASH) involves abnormal cholesterol metabolism and hepatic accumulation of toxic free cholesterol. Apical sodium-dependent bile acid transporter (ASBT) inhibition in the terminal ileum may facilitate removal of free cholesterol from the live...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiessen, Renger G., Kennedy, Ciara A., Keller, Bradley T., Levin, Nancy, Acevedo, Lisette, Gedulin, Bronislava, van Vliet, Andre A., Dorenbaum, Alejandro, Palmer, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756385/
https://www.ncbi.nlm.nih.gov/pubmed/29304731
http://dx.doi.org/10.1186/s12876-017-0736-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756385/
https://www.ncbi.nlm.nih.gov/pubmed/29304731
http://dx.doi.org/10.1186/s12876-017-0736-0

Ejemplares similares